Annual Accounts Receivable
$66.36 M
+$25.72 M+63.28%
December 31, 2023
Summary
- As of February 8, 2025, IMCR annual accounts receivable is $66.36 million, with the most recent change of +$25.72 million (+63.28%) on December 31, 2023.
- During the last 3 years, IMCR annual accounts receivable has risen by +$63.57 million (+2274.12%).
- IMCR annual accounts receivable is now at all-time high.
Performance
IMCR Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$63.66 M
+$3.41 M+5.67%
September 30, 2024
Summary
- As of February 8, 2025, IMCR quarterly accounts receivable is $63.66 million, with the most recent change of +$3.41 million (+5.67%) on September 30, 2024.
- Over the past year, IMCR quarterly accounts receivable has increased by +$11.57 million (+22.20%).
- IMCR quarterly accounts receivable is now at all-time high.
Performance
IMCR Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
IMCR Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.3% | +22.2% |
| 3 y3 years | +2274.1% | +2732.2% |
| 5 y5 years | +1095.7% | +2732.2% |
IMCR Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +713.1% | at high | +680.0% |
| 5 y | 5-year | at high | +3340.7% | at high | >+9999.0% |
| alltime | all time | at high | +3340.7% | at high | >+9999.0% |
Immunocore Holdings Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $63.66 M(+5.7%) |
| Jun 2024 | - | $60.24 M(+4.3%) |
| Mar 2024 | - | $57.75 M(+10.9%) |
| Dec 2023 | $66.36 M(+63.3%) | $52.09 M(+27.7%) |
| Sep 2023 | - | $40.80 M(+0.2%) |
| Jun 2023 | - | $40.71 M(+9.0%) |
| Mar 2023 | - | $37.36 M(+11.2%) |
| Dec 2022 | $40.64 M | $33.58 M(+16.5%) |
| Sep 2022 | - | $28.82 M(-2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $29.62 M(+34.3%) |
| Mar 2022 | - | $22.06 M(+170.3%) |
| Dec 2021 | $8.16 M(+192.0%) | $8.16 M(+263.1%) |
| Sep 2021 | - | $2.25 M(+169.3%) |
| Jun 2021 | - | $834.60 K(-11.6%) |
| Mar 2021 | - | $944.30 K(-66.2%) |
| Dec 2020 | $2.80 M(+44.9%) | $2.80 M(+1498.2%) |
| Sep 2020 | - | $174.90 K(-90.9%) |
| Dec 2019 | $1.93 M(-65.2%) | $1.93 M |
| Dec 2018 | $5.55 M | - |
FAQ
- What is Immunocore Holdings annual accounts receivable?
- What is the all time high annual accounts receivable for Immunocore Holdings?
- What is Immunocore Holdings annual accounts receivable year-on-year change?
- What is Immunocore Holdings quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Immunocore Holdings?
- What is Immunocore Holdings quarterly accounts receivable year-on-year change?
What is Immunocore Holdings annual accounts receivable?
The current annual accounts receivable of IMCR is $66.36 M
What is the all time high annual accounts receivable for Immunocore Holdings?
Immunocore Holdings all-time high annual accounts receivable is $66.36 M
What is Immunocore Holdings annual accounts receivable year-on-year change?
Over the past year, IMCR annual accounts receivable has changed by +$25.72 M (+63.28%)
What is Immunocore Holdings quarterly accounts receivable?
The current quarterly accounts receivable of IMCR is $63.66 M
What is the all time high quarterly accounts receivable for Immunocore Holdings?
Immunocore Holdings all-time high quarterly accounts receivable is $63.66 M
What is Immunocore Holdings quarterly accounts receivable year-on-year change?
Over the past year, IMCR quarterly accounts receivable has changed by +$11.57 M (+22.20%)